TABLE 4.
Key preclinical studies on combinatorial therapies for SCI.
Author | Year | Modality | Result |
---|---|---|---|
Amr et al. 60 | 2014 | Chitosan-laminin scaffold | Motor and sensory levels improved |
Chen et al. 61 | 2020 | NeuroRegen Scaffolds | Partial shallow sensory and autonomic nervous functional improvements |
Zhao et al. 62 | 2017 | NeuroRegen Scaffold | Expansion of sensation level and motor-evoked potential (MEP)-responsive area, increased finger activity, enhanced trunk stability, defecation sensation, and autonomic neural function recovery |
Yoon et al. 34 | 2007 | Granulocyte-macrophage-colony stimulating factor | Improved functional recovery |
Zhu et al. 64 | 2016 | Mononuclear Cell | Improved locomotor function |
SCI, spinal cord injury.